vedolizumab,ustekinumab,adalimumab,risankizumab,tofacitinib,infliximab,golimumab,ozanimod
abbvie,janssen,bms,pfizer,takeda
['tofacitinib', ' uc ', 'tofa', 'infliximab', 'golimumab', 'adalimumab', 'risan', 'ibd', 'ozanimod', ' vedo', 'ustekinumab', 'vedolizumab']
per dr hanauer. we need advanced therapies for treatment but we have limited access due to payer issues. we need steroid but even then our success at getting off is still not see below #aibd2022 